Form 4: Arcus Biosciences Director Yasunori Kaneko Buys 20,000 Shares

Director Yasunori Kaneko of Arcus Biosciences, Inc. [RCUS] recently purchased 20,000 shares of common stock at an average price of $10.06.

Summary

• On February 27, 2025, Yasunori Kaneko, a director of Arcus Biosciences, acquired 20,000 shares of common stock.
• The shares were purchased at a weighted average price of $10.06, with individual transactions ranging from $10.00 to $10.16.
• Following the transaction, Kaneko directly owns 28,400 shares.
• Kaneko also indirectly owns 252,524 shares through Kaneko Investments, LLC, 152,981 shares through a trust, and 505,050 shares through Kaneko Capital, LLC.

Sentiment

Score: 6

Explanation: Neutral sentiment. The document simply reports a stock purchase by a director, which could be seen as a positive signal, but without further context, it's difficult to gauge the overall impact.

Positives

• The director's purchase could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The stock purchase by a director could positively influence shareholder sentiment.

Key Dates